SNT 25.7% 4.4¢ syntara limited

short away markie, 30c+ in cash backing, new trial results soon...

  1. 2,833 Posts.
    short away markie, 30c+ in cash backing, new trial results soon to be release and selling in some markets already.

    while the outcome with the fda is what it is, pxs should have only gone with the over 18 population and done a new trial in the over 6 like has been talked about in the european market.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.